UL users are granted trial access to the Wolters Kluwer pharmaceutical e-resource UpToDate Lexidrug until November 30, 2024.

UpToDate Lexidrug is an evidence-based drug reference solution that provides access to comprehensive pharmaceutical information all in one resource, supporting efficient and timely drug decision-making.

Lexidrug contains more than 2500 drug monographs and 8500 patient education leaflets, as well as various tools such as 200 medical calculators, drug interaction and compatibility tools, drug ID, toxicology database and more. The platform is created for easy navigation without having to interrupt workflow and efficient access to information.

If you already have an UpToDate account, you can access Lexidrug from it at the time of the trial.

Another way to access is by sending a request for login information to info-bibl@lu.lv or agnese.arabere@lu.lv.

You can also use the Lexidrug mobile app by following instructions here.

Apple Store: https://apps.apple.com/us/app/uptodate-lexidrug/id313401238

Google Play Store: https://play.google.com/store/apps/details?id=com.lexi.android&hl=en_US

User Guide

Mobile App User Guide

Video

The Library of the UL invites you to express your opinion about the Wolters Kluwer pharmaceutical e-resource UpToDate Lexidrug by sending feedback to the e-mail address info-bibl@lu.lv or agnese.arabere@lu.lv.

Your feedback helps us evaluate e-resource subscriptions in the future!

Share